MedPath

NEO-SYNEPHRINE NASAL SPRAY

NEO-SYNEPHRINE NASAL SPRAY

Discontinued
DIN Number

02150565

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

bayer inc consumer care

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02150565
AIG Number0200774001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R01AB01 PHENYLEPHRINE
Product Specifications
Dosage FormSpray
Route of AdministrationNasal
AHFS Classification52:32.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

PHENYLEPHRINE HYDROCHLORIDEActive
Strength: .5 %
Monograph: PHENYLEPHRINE HYDROCHLORIDE
THENYLDIAMINE HYDROCHLORIDEActive
Strength: .1 %
Monograph: THENYLDIAMINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.